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The transcription factor HIF-1 mediates adaptive responses to hypoxia, and its activity is 
negatively regulated by O2-dependent binding of the von Hippel-Lindau (VHL) protein. In this 
issue, Boutin et al. (2008) use conditional knockout mice to demonstrate that sensing of O2 
by keratinocytes in the epidermis leads to alterations in cutaneous blood flow that affect the 
production of the hormone erythropoietin, thereby modulating red blood cell production and 
the O2-carrying capacity of blood.The physiology of modern day mam-
mals has been shaped by natural selec-
tion over the past several billion years, 
during which life on Earth has thrived 
in an O2-rich environment. Metazoan 
species evolved a key protein, the 
transcription factor hypoxia-inducible 
factor 1 (HIF-1), to regulate O2 delivery 
to tissues. Decreased O2 in the blood 
of mammals is sensed by the carotid 
body, which is located at the bifurcation 
of the common carotid artery and acti-
vates the cardiovascular and respiratory 
centers in the central nervous system to 
increase ventilation and cardiac output 
(Kline et al., 2002). A reduction in O2 
is also sensed by cells in the liver and 
kidney, which respond by producing 
erythropoietin (EPO), the hormone that 
controls red blood cell production and, 
thus, the O2-carrying capacity of blood 
(Stockmann and Fandrey, 2006). HIF-1, 
originally discovered as the factor that 
mediates hypoxia-induced transcrip-
tion of the human EPO gene (Semenza 
and Wang, 1992), is also required for O2 
sensing by the carotid body (Kline et al., 
2002). HIF-1 is composed of two sub-
units: constitutively expressed HIF-1β 
and O2-regulated HIF-1α (Wang et al., 
1995). Database searches led to the 
identification of HIF-2α, which is also 
regulated by O2, dimerizes with HIF-1β, 
and regulates an overlapping but dis-
tinct battery of target genes (Elvidge et 
al., 2006; Patel and Simon, 2008). Under 
normoxic conditions, HIF-1α and HIF-2α 
are subjected to hydroxylation on pro-
line residues (402 and 564 in human 
HIF-1α). The modification is required 206 Cell 133, April 18, 2008 ©2008 Elsevier for the binding of the von Hippel-Lindau 
(VHL) tumor suppressor protein, the rec-
ognition component of an E3 ubiquitin-
protein ligase that targets HIF-1α for 
proteasomal degradation (Kaelin, 2005; 
Schofield and Ratcliffe, 2005). Under 
hypoxic conditions, hydroxylation is 
inhibited and the VHL protein does not 
bind to HIF-1, leading to the accumula-
tion of HIF-1α and HIF-2α.
Homozygous deletion in the mouse 
germline of the Hif-1α or Vhl locus 
results in embryonic lethality. Using Cre-
lox technology to generate conditional 
knockout mice at these loci in specific 
cell types and at specific time points 
in postnatal life has provided insights 
into complex homeostatic mechanisms, 
which may not have been possible using 
other approaches. That has certainly 
proven to be the case with the deletion 
of these genes in mouse epidermal cells 
(keratinocytes) as Randy Johnson and 
colleagues report in this issue (Boutin et 
al., 2008). They show that deletion of the 
Vhl gene in mouse keratinocytes results 
in increased EPO levels in plasma and 
development of polycythemia, a con-
dition in which too many red blood 
cells are produced and blood viscosity 
increases. Interestingly, humans with 
an inherited form of polycythemia are 
homozygous for a germline missense 
mutation that reduces, but does not 
eliminate, VHL activity (Ang et al., 2002). 
But given that EPO is not expressed in 
the skin, how does loss of the VHL pro-
tein in mouse keratinocytes result in 
increased production of EPO and red 
blood cells?Inc.The skin is perfused by capillaries 
that are located in the dermis (Figure 1). 
Regulation of cutaneous blood flow is 
an important component of the homeo-
static mechanism that maintains the 
human core body temperature at 37°C 
despite wide fluctuations in environmen-
tal temperature. Vasodilation of dermal 
capillaries increases heat loss, whereas 
vasoconstriction prevents it. As Boutin 
et al. (2008) now show, deletion of VHL 
in mouse keratinocytes causes a marked 
increase in cutaneous blood flow and 
dysregulated expression of HIF-1α 
and especially HIF-2α. This results 
in the expression of HIF-1-regulated 
genes, including Nos2, which encodes 
inducible nitric oxide synthase. The 
expression of Nos2 leads to increased 
generation of nitric oxide (NO), a potent 
vasodilator. Cutaneous vasodilation, 
that is, more blood flow to the skin, 
results in less blood flow to other organs. 
In the liver, blood flow is sufficiently 
reduced to result in tissue hypoxia, a 
condition that induces expression of the 
Epo gene. Consistent with this mecha-
nism for increased EPO production, 
Boutin et al. did not observe elevated 
EPO expression in the keratinocyte-
specific Vhl knockout mice that also 
lacked either HIF-2α (in keratinocytes) 
or NOS2 (in all cells). Remarkably, 
transdermal administration of nitroglyc-
erin (an NO donor) to wild-type mice 
boosted plasma levels of EPO, whereas 
systemic treatment did not. Thus, the 
homeostatic mechanism for maintain-
ing the O2-carrying capacity of blood 
can be disrupted by the dysregulation 
of cutaneous blood flow (Fig-
ure 1). But do these intriguing 
observations have any rele-
vance for normal mammalian 
physiology?
To answer this question, the 
authors performed two exper-
iments, one mundane and the 
other insane. In the mundane 
experiment, they eliminated 
the expression of either HIF-1α 
or HIF-2α in mouse keratino-
cytes expressing wild-type 
VHL and analyzed the effect 
on hypoxia-induced EPO pro-
duction. One might predict 
that keratinocyte-specific loss 
of HIF-2α would impair EPO 
production in response to 
hypoxia, but surprisingly, loss 
of HIF-2α had no effect. But 
when mice with a keratinocyte-
specific deletion of HIF-1α 
were exposed to hypoxia, the 
predicted increase in plasma 
EPO levels was blunted and 
induction of EPO expression 
in the kidney was lost. These 
results suggest that physi-
ological regulation of cutane-
ous blood flow in response to 
changes in atmospheric O2 is 
mediated by HIF-1α, whereas 
the pathological dysregulation 
resulting from VHL loss-of-
function is primarily mediated 
by HIF-2α (Figure 1). Taken 
together, these results sup-
port the conclusion that HIF-1 
activity in the skin is important 
for EPO production by the kid-
ney in response to hypoxia.
To bolster this conclusion, 
Johnson's colleague Frank 
Powell performed the insane 
experiment. He designed 
what can best be described 
as a contraption (see supple-
mental figure in Boutin et al., 
2008) to allow the investiga-
tors to deliver a different O2 concentra-
tion to the head (and thus the lungs) of 
mice relative to the body (and thus the 
skin). Using this contraption, the inves-
tigators found that when mice respired 
under hypoxic conditions but perspired 
under normoxic conditions, EPO levels 
were significantly elevated relative to ani-
mals whose lungs and skin were exposed 
to hypoxia. The lack of EPO produc-
tion in mice whose skin and lungs were 
exposed to hypoxic conditions suggests 
that during an acute exposure to envi-
ronmental hypoxia, blood flow to the skin 
is reduced, thereby allowing increased 
blood flow to the vital organs. However, 
when the skin is exposed to 
normoxia but the lungs are 
exposed to hypoxia, the skin 
no longer senses hypoxia 
and cutaneous vasoconstric-
tion does not occur. Hence, 
blood flow to vital organs is 
reduced (relative to mice in 
which both skin and respira-
tory tract were exposed to 
hypoxia), thereby resulting in 
greater EPO production. The 
conclusion that acute envi-
ronmental hypoxia induces 
cutaneous vasoconstriction 
is surprising because, in gen-
eral, the systemic vasculature 
dilates in response to acute 
hypoxia (through produc-
tion of vasodilators such as 
NO), whereas the pulmonary 
vasculature constricts (to 
shunt blood flow away from 
areas of the lung that are 
not being oxygenated). The 
authors further report that 
key mediators of pulmonary 
vasoconstriction, the volt-
age-gated potassium chan-
nel Kv1.5 and the secreted 
peptide endothelin 1, are also 
expressed under HIF-1 con-
trol in the dermal vasculature 
in response to hypoxia. Elec-
trophysiological studies are 
required to further investigate 
whether smooth muscle cells 
from dermal vessels show 
responses to changes in O2 
that are similar to those of pul-
monary artery smooth muscle 
cells and whether Kv1.5 and 
endothelin 1 are involved. The 
cutaneous vasoconstrictor 
response is not maintained 
(perhaps due to adverse 
long-term consequences to 
the skin of reduced cutane-
ous blood flow), and chronic 
hypoxia leads to vasodilation 
of dermal capillaries, perhaps through 
increased NOS2 production (Figure 1).
Everyone learns in high school biology 
that frogs can respire through their skin. 
Does transcutaneous O2 uptake occur 
in mice as well? Probably not. Frog epi-
dermis is thin and contains a vast capil-
lary network, whereas mouse epidermis 
Figure 1. An Epidermal Response to Hypoxia
Loss of the VHL protein in epidermal keratinocytes results in constitutive 
expression of the transcription factors HIF-1α and HIF-2α, leading to in-
creased expression of Nos2 and enhanced production of the vasodilator 
nitric oxide (NO). NO diffuses into dermal capillaries and induces vasodila-
tion, thereby increasing blood flow to the skin and decreasing blood flow 
to the kidneys and liver. The resultant tissue hypoxia in these organs in-
duces the expression of HIF-1α and HIF-2α, which mediate the production 
of EPO and its secretion into the blood. In the bone marrow, EPO binds 
to erythroid progenitor cells and promotes their survival and proliferation, 
leading to an increase in mature red blood cells that transport O2 to all tis-
sues in the body. (Inset) In response to acute ambient hypoxia (such as a 
rapid ascent to high altitude), cutaneous vasoconstriction (perhaps medi-
ated by the potassium channel Kv1.5 and endothelin 1) increases blood 
flow to vital organs to maintain their oxygenation. However, this response 
is not sustained and chronic hypoxia leads to cutaneous vasodilation, per-
haps through expression of Nos2 and production of NO.Cell 133, April 18, 2008 ©2008 Elsevier Inc. 207
is thicker and is not vascularized, thus 
resulting in a diffusion distance between 
air and dermal capillaries that is too 
great to serve as an efficient means of 
O2 uptake.
Finally, does dysregulation of cutane-
ous blood flow have any effect on body 
temperature homeostasis? Remarkably, 
mice lacking VHL in their keratinocytes 
die from hypothermia when subjected to 
cold stress due to a failure of cutaneous 
vasoconstriction (R. Johnson et al., per-
sonal communication). Considering the 
complex homeostatic mechanisms that 
are subserved by the cutaneous vascu-208 Cell 133, April 18, 2008 ©2008 Elsevier I
Acute lung injury (ALI) affects more than 
200,000 people in the US each year, with 
approximately 75,000 deaths, making it 
an important cause of morbidity, mortal-
ity, and health care expenditure (Ruben-
feld et al., 2005). Bacterial and viral 
infections are important risk factors for 
ALI, but aspiration of gastric contents, 
major trauma, and repeated transfusions 
are additional risks. ALI is also a leading 
cause of death in people infected with 
H5N1 avian influenza virus or the coro-
navirus that causes SARS (severe acute 
respiratory syndrome). In this issue, Imai 
et al. (2008) report surprising insights 
from murine studies that provide a new 
perspective on the mechanisms contrib-
uting to ALI in humans.
The alveolar membrane of the lungs is 
the largest surface area of the body that 
is in continuous contact with the out-
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side environment, and a complex set of 
defenses have evolved to protect it against 
inhaled particulates and microbes. The 
alveolar wall is a delicate structure, con-
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basement membrane composed of col-
lagens, glycoproteins, and glycosamino-
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5514.membrane causes the clinical syndrome 
of ALI, in which the alveolar spaces fill 
with proteinaceous exudates, producing 
severe alterations in gas exchange, criti-
cal hypoxemia, and death in the absence 
of aggressive medical care. The hallmark 
findings of ALI include acute neutrophilic 
inflammation and an array of proinflam-
matory cytokines in the lungs, suggest-
ing that activation of innate immunity 
is an initial event, whether or not overt 
infection is present. Activation of innate 
immune pathways combined with the 
physical stresses created by mechanical 
ventilation cause a synergistic increase 
in lung injury, but the mechanisms 
underlying ALI are not clear (Dos Santos 
and Slutsky, 2006).
In order to identify susceptibility fac-
tors for lung injury, Imai and colleagues 
screened several strains of mice using a 
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